Go Pro

Amrize Ltd (NYSE:AMRZ) Given Average Rating of "Hold" by Analysts

Amrize logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts rate Amrize “Hold” on average: Of 19 covering firms, eight recommend holding, six recommend buying, four rate it a sell and one issues a strong buy. The average 12-month price target is $54.25.
  • The stock faces mixed signals and recent weakness: Shares opened at $38.63, near their 52-week low of $37.38, while several analysts cut ratings or price targets. Amrize also missed quarterly EPS estimates, reporting $0.88 versus the expected $0.92.
  • Insiders have been buying shares: Executives, including CEO Jan Jenisch, purchased a combined 48,983 shares worth about $2.16 million over the past 90 days. The company also paid a quarterly dividend of $0.11 per share.
  • Five stocks to consider instead of Amrize.

Shares of Amrize Ltd (NYSE:AMRZ - Get Free Report) have received a consensus rating of "Hold" from the nineteen research firms that are currently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a sell rating, eight have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $54.25.

Several research analysts recently issued reports on AMRZ shares. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Amrize in a research report on Friday, June 26th. Royal Bank Of Canada lowered Amrize from a "sector perform" rating to an "underperform" rating and reduced their price target for the company from $60.00 to $48.00 in a research report on Monday, August 10th. Morgan Stanley set a $63.00 price target on Amrize and gave the company an "overweight" rating in a research note on Monday, June 22nd. Bank of America restated an "underperform" rating and set a $40.00 price objective (down from $50.00) on shares of Amrize in a research report on Wednesday, September 2nd. Finally, Citigroup lowered Amrize from a "buy" rating to a "cautious" rating in a research note on Wednesday, September 9th.

Read Our Latest Stock Report on Amrize

Amrize Trading Up 2.9%

Shares of NYSE AMRZ opened at $38.63 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10. Amrize has a 52-week low of $37.38 and a 52-week high of $65.94. The firm has a 50 day moving average price of $45.77 and a two-hundred day moving average price of $51.38. The stock has a market cap of $21.37 billion, a P/E ratio of 17.80, a price-to-earnings-growth ratio of 1.16 and a beta of 0.04.

Amrize (NYSE:AMRZ - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The business had revenue of $3.49 billion for the quarter. As a group, equities analysts forecast that Amrize will post 2.57 EPS for the current year.

Amrize Announces Dividend

The company also recently declared a dividend, which was paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th were issued a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 18th. Amrize's dividend payout ratio (DPR) is presently 20.28%.

Insider Transactions at Amrize

In other news, insider Mario Gross acquired 3,568 shares of Amrize stock in a transaction dated Tuesday, August 11th. The shares were bought at an average cost of $46.60 per share, with a total value of $166,268.80. Following the purchase, the insider owned 38,485 shares in the company, valued at $1,793,401. This trade represents a 10.22% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Jan Jenisch acquired 26,000 shares of the firm's stock in a transaction dated Wednesday, September 2nd. The shares were purchased at an average price of $42.47 per share, with a total value of $1,104,220.00. Following the completion of the transaction, the chief executive officer owned 1,767,000 shares of the company's stock, valued at $75,044,490. This trade represents a 1.49% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders have acquired 48,983 shares of company stock worth $2,158,755. Company insiders own 0.54% of the company's stock.

Institutional Trading of Amrize

A number of large investors have recently bought and sold shares of the business. Norges Bank bought a new stake in shares of Amrize during the 4th quarter valued at about $929,333,000. Geode Capital Management LLC increased its holdings in Amrize by 3.4% in the fourth quarter. Geode Capital Management LLC now owns 6,093,012 shares of the company's stock worth $328,080,000 after purchasing an additional 198,810 shares in the last quarter. Pictet Asset Management Holding SA increased its holdings in Amrize by 4.7% in the first quarter. Pictet Asset Management Holding SA now owns 5,216,765 shares of the company's stock worth $283,017,000 after purchasing an additional 234,731 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Amrize by 3.7% in the first quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company's stock valued at $263,371,000 after buying an additional 171,622 shares during the period. Finally, Barclays PLC lifted its stake in Amrize by 95.4% in the fourth quarter. Barclays PLC now owns 4,614,593 shares of the company's stock valued at $249,557,000 after buying an additional 2,253,431 shares during the period.

About Amrize

(Get Free Report)

Amrize is a North American building materials and solutions company formed through the separation of Holcim's North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.

Featured Stories

Analyst Recommendations for Amrize (NYSE:AMRZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines